The ROE (Return on Equity) of Talis Biomedical Corp (TLIS) is -89.71%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2023-12-31 | -89.71% |
| 2022-12-31 | -89.17% |
| 2021-12-31 | -82.07% |
| 2020-12-31 | -49.97% |
| 2019-12-31 | -127.11% |
| 2018-12-31 | -277.32% |